BoneKEy Knowledge Environment May 2014
BoneKEy Watch
- Title
- Chloroquine and osteoclastogenesis; the role of TRAF3 and potential for future therapeutics
- DOI
- 10.1038/bonekey.2014.34
- No PDF available
- Title
- Single SNP in a myosin gene identified as the source of the mini-muscle phenotype
- DOI
- 10.1038/bonekey.2014.42
- No PDF available
- Title
- Do LRP5 mutations impact on serotonin levels in plasma, serum or platelets?
- DOI
- 10.1038/bonekey.2014.41
- No PDF available
- Title
- Evidence for a novel parathyroid-specific signaling pathway in calcium homeostasis
- DOI
- 10.1038/bonekey.2014.33
- No PDF available
- Title
- The angiopoietin-like protein 2 may be a useful therapeutic target to prevent osteosarcoma metastasis
- DOI
- 10.1038/bonekey.2014.28
- No PDF available
- Title
- Denosumab for osteoporosis has no impact on aortic calcification or adverse CV events
- DOI
- 10.1038/bonekey.2014.35
- No PDF available
- Title
- Nucleation hypothesis to explain how mineralization of matrices occurs in vivo
- DOI
- 10.1038/bonekey.2014.30
- No PDF available
- Title
- AML and CML are regulated differently by cells within the bone marrow microenvironment
- DOI
- 10.1038/bonekey.2014.27
- No PDF available
- Title
- Genetic risk factors help increase the accuracy of fracture prediction in postmenopausal women
- DOI
- 10.1038/bonekey.2014.40
- No PDF available
- Title
- miRNAs within osteoclasts regulate osteolytic bone metastasis and could be important biomarkers
- DOI
- 10.1038/bonekey.2014.26
- No PDF available
- Title
- Romosozumab, a sclerostin-blocking antibody, increases BMD in postmenopausal women
- DOI
- 10.1038/bonekey.2014.32
- No PDF available
- Title
- Predicting fracture risk using nonlinear micro-finite element simulations
- DOI
- 10.1038/bonekey.2014.29
- No PDF available
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.